Tag: serplulimab
Fosun Pharma signs licensing deal with Henlius Biotech for serplulimab
Fosun Pharma has signed an exclusive US licensing agreement with Shanghai Henlius Biotech for commercializing the latter’s serplulimab, an anti-PD-1 monoclonal antibody (mAb). The financial ... Read More